← back to search

Arvind Venkataraman

University of Washington · US
Area of research
Infectious Diseases · Environmental Engineering
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, SARS-CoV-2 detection and testing, COVID-19 Clinical Research Studies, and Microbial Fuel Cells and Bioremediation.
h-index
32
citations
11,542
works
62
NIH funding
primary concept
Biology
email

Recent publications

Multiscale PHATE identifies multimodal signatures of COVID-19
Nature Biotechnology 2022cited by 80position: middledoi
Delayed production of neutralizing antibodies correlates with fatal COVID-19
Nature Medicine 2021cited by 263position: middledoi
Antibodies against human endogenous retrovirus K102 envelope activate neutrophils in systemic lupus erythematosus
The Journal of Experimental Medicine 2021cited by 68position: middledoi
Author Correction: Delayed production of neutralizing antibodies correlates with fatal COVID-19
Nature Medicine 2021cited by 8position: middledoi
Reply to: A finding of sex similarities rather than differences in COVID-19 outcomes
Nature 2021cited by 4position: middledoi
Longitudinal analyses reveal immunological misfiring in severe COVID-19
Nature 2020cited by 2,289position: middledoi
Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2
New England Journal of Medicine 2020cited by 1,048position: middledoi
Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT–qPCR primer–probe sets
Nature Microbiology 2020cited by 914position: middledoi
Detection of SARS-CoV-2 RNA by multiplex RT-qPCR
PLoS Biology 2020cited by 92position: middledoi
Vitamin B12 and folic acid alleviate symptoms of nutritional deficiency by antagonizing aryl hydrocarbon receptor
Proceedings of the National Academy of Sciences 2020cited by 39position: middledoi
Multicenter Comparison of Lung and Oral Microbiomes of HIV-infected and HIV-uninfected Individuals
American Journal of Respiratory and Critical Care Medicine 2015cited by 152position: middledoi
Metabolite transfer with the fermentation product 2,3-butanediol enhances virulence by <i>Pseudomonas aeruginosa</i>
The ISME Journal 2014cited by 98position: firstdoi
Comparison of the Respiratory Microbiome in Healthy Nonsmokers and Smokers
American Journal of Respiratory and Critical Care Medicine 2013cited by 845position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Akiko Iwasaki · Yale University3 papers (2020–2021)Alison Morris · Rutgers, The State University of New Jersey2 papers (2013–2015)Sonia C. Flores · Georgia Gwinnett College2 papers (2013–2015)James M. Beck · University of Colorado Denver2 papers (2013–2015)Homer L. Twigg · Indiana University School of Medicine2 papers (2013–2015)Erica Sodergren · Jackson Laboratory2 papers (2013–2015)Thomas M. Schmidt · University of Michigan2 papers (2013–2015)Susan V. Lynch · L'Oreal (United States)2 papers (2013–2015)Vincent B. Young · University of Pennsylvania2 papers (2013–2015)Jeffrey L. Curtis · VA Ann Arbor Healthcare System2 papers (2013–2015)George M. Weinstock · Jackson Laboratory2 papers (2013–2015)Kristina Crothers · University of North Carolina at Chapel Hill2 papers (2013–2015)Patrick D. Schloss · University Hospital Heidelberg2 papers (2013–2015)Maria Tokuyama · University of British Columbia2 papers (2020–2021)Andrew P. Fontenot · Progenics Pharmaceuticals (United States)2 papers (2013–2015)Laurence Huang · University of California, San Francisco2 papers (2013–2015)Elodie Ghedin · National Institutes of Health2 papers (2013–2015)Rebecca Earnest · University of Nebraska Medical Center1 papers (2020–2020) · 1 papers (2020–2020)Karen H. Costenbader · Harvard University1 papers (2021–2021)